Bristol-Myers Squibb (BMY) News Today $48.26 +0.41 (+0.86%) Closing price 05/30/2025 03:59 PM EasternExtended Trading$48.27 +0.01 (+0.02%) As of 05/30/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 1% - Here's What HappenedBristol-Myers Squibb (NYSE:BMY) Trading 1% Higher - Should You Buy?May 30 at 2:08 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by NorthCrest Asset Manangement LLCNorthCrest Asset Manangement LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 114,959 shares of the biopharmaceutiMay 30 at 5:33 AM | marketbeat.comPKO Investment Management Joint Stock Co Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)PKO Investment Management Joint Stock Co purchased a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 16,000 shares of the biopharmaceutical company's stock, valued at approximatelyMay 30 at 5:31 AM | marketbeat.comSiemens Fonds Invest GmbH Sells 44,507 Shares of Bristol-Myers Squibb (NYSE:BMY)Siemens Fonds Invest GmbH decreased its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 64.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 24,994 shares of the biopharmaceutical company's stock after selling 44,507 shareMay 30 at 5:14 AM | marketbeat.comDividend Discounts: 5 Cheap Stocks Yielding Up to 7.6%May 29 at 10:09 PM | marketbeat.comFairtree Asset Management Pty Ltd Invests $550,000 in Bristol-Myers Squibb (NYSE:BMY)Fairtree Asset Management Pty Ltd bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,720 shares of the biopMay 29 at 7:50 AM | marketbeat.comChancellor Financial Group WB LP Purchases Shares of 8,673 Bristol-Myers Squibb (NYSE:BMY)Chancellor Financial Group WB LP acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,673 shares of the biopharmaceuticalMay 29 at 7:47 AM | marketbeat.com111 Capital Purchases New Holdings in Bristol-Myers Squibb (NYSE:BMY)111 Capital purchased a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 17,532 shares of the biopharmaceutical company's stock, valued at approximately $992,000. Other institutional investMay 29 at 7:29 AM | marketbeat.comTwo Sigma Investments LP Sells 4,635,617 Shares of Bristol-Myers Squibb (NYSE:BMY)Two Sigma Investments LP lessened its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 98.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 85,624 shares of the biopharmaceutical company's stock aMay 29 at 3:58 AM | marketbeat.comBristol-Myers Squibb Company (BMY) Bernstein 41st Annual Strategic Decisions Conference (Transcript)May 28 at 7:13 PM | seekingalpha.comBristol-Myers Squibb's Painful Pullback Has Triggered Richer Dividend Story - Upgrade To BuyMay 28 at 12:58 PM | seekingalpha.comBristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor IndicationsMay 28 at 6:55 AM | businesswire.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Bristol-Myers Squibb (NYSE:BMY)Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,764,114 shares of theMay 28 at 6:20 AM | marketbeat.comEmployees Retirement System of Texas Has $2.32 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)Employees Retirement System of Texas decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 27.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 41,042 shares of the biopharmaMay 28 at 6:12 AM | marketbeat.comAmeriflex Group Inc. Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)Ameriflex Group Inc. acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,463 shares of the biopharmaceutical company's stock, valued at approximately $3May 28 at 5:39 AM | marketbeat.comBristol-Myers Squibb: This Undervalued Dog Needs An Option CollarMay 27, 2025 | seekingalpha.comBristol-Myers: Among The Cheapest Pharma Names, Now Yielding Above 5%May 27, 2025 | seekingalpha.comBristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market TurbulenceMay 27, 2025 | seekingalpha.comLeigh Baldwin & CO. LLC Makes New $534,000 Investment in Bristol-Myers Squibb (NYSE:BMY)Leigh Baldwin & CO. LLC bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 9,443 shares of the biopharmaceutical compaMay 27, 2025 | marketbeat.comB. Riley Wealth Advisors Inc. Sells 5,744 Shares of Bristol-Myers Squibb (NYSE:BMY)B. Riley Wealth Advisors Inc. trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 147,366 shares of the biopharmaceutical company's stock aftMay 27, 2025 | marketbeat.com294,400 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 294,400 shares of the biopharmaceutiMay 27, 2025 | marketbeat.com5,815 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Hall Capital Management Co. Inc.Hall Capital Management Co. Inc. purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 5,815 shares of the biopharmaceutical companyMay 27, 2025 | marketbeat.com10,000 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Aurdan Capital Management LLCAurdan Capital Management LLC bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 10,000 shares of the biopharmaceutical companyMay 27, 2025 | marketbeat.comForum Financial Management LP Acquires 5,462 Shares of Bristol-Myers Squibb (NYSE:BMY)Forum Financial Management LP boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 47.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,884 shares of the biopharmaceutiMay 27, 2025 | marketbeat.comAscent Group LLC Increases Position in Bristol-Myers Squibb (NYSE:BMY)Ascent Group LLC grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 37.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,469 shares of the biopharmaceutical company's stock after buyiMay 27, 2025 | marketbeat.com49,748 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by GF Fund Management CO. LTD.GF Fund Management CO. LTD. acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 49,748 shares of the biopharmaceutical company's stock, valued at approxiMay 27, 2025 | marketbeat.comMackenzie Financial Corp Raises Stake in Bristol-Myers Squibb (NYSE:BMY)Mackenzie Financial Corp raised its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 84.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 585,766 shares of the biopharmaceutical company's stock after acquMay 27, 2025 | marketbeat.comWhen It Rains Gold, Put Out The Bucket: 2 Wonderful Income BargainsMay 26, 2025 | seekingalpha.comParr Mcknight Wealth Management Group LLC Purchases New Stake in Bristol-Myers Squibb (NYSE:BMY)Parr Mcknight Wealth Management Group LLC purchased a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,539 shares of the biopharmaceutical company's sMay 26, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Stock Holdings Decreased by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 19.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 897,664 shares of the biopharMay 25, 2025 | marketbeat.comPacific Point Advisors LLC Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)Pacific Point Advisors LLC bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 9,802 shares of the biopharmaceutical company's stock,May 25, 2025 | marketbeat.comVise Technologies Inc. Has $2.54 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Vise Technologies Inc. raised its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 34.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 44,870 shares of the biopharmaceutical companyMay 25, 2025 | marketbeat.comFocus Partners Advisor Solutions LLC Lowers Stake in Bristol-Myers Squibb (NYSE:BMY)Focus Partners Advisor Solutions LLC decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 39.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,054 shares of the biopharmaceuticaMay 25, 2025 | marketbeat.comWaverly Advisors LLC Has $1.82 Million Stake in Bristol-Myers Squibb (NYSE:BMY)Waverly Advisors LLC lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 140.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,099 shares of the biopharmMay 25, 2025 | marketbeat.comWith 81% ownership, Bristol-Myers Squibb Company (NYSE:BMY) boasts of strong institutional backingMay 24, 2025 | uk.finance.yahoo.comJT Stratford LLC Buys 22,929 Shares of Bristol-Myers Squibb (NYSE:BMY)JT Stratford LLC lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 215.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,554 shares of the biopharmaceutical company's stock aMay 24, 2025 | marketbeat.comInspire Trust Co. N.A. Sells 45,500 Shares of Bristol-Myers Squibb (NYSE:BMY)Inspire Trust Co. N.A. lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 44.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,000 shares of the biopharmaceutical company's stock afteMay 24, 2025 | marketbeat.comBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Increases Stake in Bristol-Myers Squibb (NYSE:BMY)BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38May 24, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Showcases Breakthrough Oncology Data at ASCO 2025 MeetingMay 23, 2025 | uk.finance.yahoo.comCss LLC Il Raises Stake in Bristol-Myers Squibb (NYSE:BMY)Css LLC Il lifted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 19.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,940 shares of the biopharmaceutical company's stock after purchasing an additioMay 23, 2025 | marketbeat.comUSS Investment Management Ltd Sells 46,833 Shares of Bristol-Myers Squibb (NYSE:BMY)USS Investment Management Ltd trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 11.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 353,836 shares of the biopharmaceutical company's stock after sellingMay 23, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Westwood Holdings Group Inc.Westwood Holdings Group Inc. grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 397.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 25,191 shares of the biopharmaceutical company's stock after purchasing an additioMay 23, 2025 | marketbeat.comTidal Investments LLC Has $5.10 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Tidal Investments LLC cut its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 28.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,197 shares of the biopharmaceutical company's stock aftMay 23, 2025 | marketbeat.comBristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research PipelineMay 22, 2025 | businesswire.comLantern Wealth Advisors LLC Purchases 11,352 Shares of Bristol-Myers Squibb (NYSE:BMY)Lantern Wealth Advisors LLC raised its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 77.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 26,032 shares of the biopharmaceutical company's stock after acquiring an additionMay 22, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 3,196,919 Shares of Bristol-Myers Squibb (NYSE:BMY)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,271,742 sharMay 22, 2025 | marketbeat.comWesleyan Assurance Society Sells 9,811 Shares of Bristol-Myers Squibb (NYSE:BMY)Wesleyan Assurance Society decreased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 59,492 shares of the biopharmaceutical company's sMay 22, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Woodline Partners LPWoodline Partners LP increased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 100.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,561,622 shares of the biopMay 22, 2025 | marketbeat.comZimmer Partners LP Buys New Position in Bristol-Myers Squibb (NYSE:BMY)Zimmer Partners LP bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 378,000 shares of the biopharmaceutical company's stock, valued atMay 22, 2025 | marketbeat.comZurich Insurance Group Ltd FI Purchases 422,804 Shares of Bristol-Myers Squibb (NYSE:BMY)Zurich Insurance Group Ltd FI grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 707.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 482,604 shares of the bioMay 22, 2025 | marketbeat.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.290.87▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼3836▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
